Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00269126
Status:
COMPLETED
Last Update Posted:
2013-04-15
First Post:
2005-12-21
Brief Title:
Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease Chronic Bronchitis Emphysema
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
See Detailed Description
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study compares the effect of two medicines on COPD Chronic Obstructive Pulmonary Disease This study will last up to 18 weeks and subjects will visit the clinic 5 times Subjects will be given breathing tests and will record their breathing symptoms daily on diary cards
Detailed Description:
Clinical Evaluation of GW815SF for Chronic Obstructive Pulmonary Disease Chronic Bronchitis Emphysema Assessment of the Effect of Addition of Fluticasone Dipropionate to Salmeterol Xinafoate 50µg after Switching under Double-blinded conditions to GW815SF 50250µg in Chronic Obstructive Pulmonary Disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None